Skip to main content
TheraLuma
Clinical Tool

Photobiomodulation Therapy (PBMT) Clinical Dashboard

LED wavelength selection, optical attenuation, and WALT dosimetry guidance for physical therapy and chiropractic practice.

PBMT Fundamental Mechanism of Action*

Photobiomodulation therapy (PBMT) uses non-ionizing light in the visible red 630-670 nm and near-infrared 780-950 nm spectra to stimulate cellular energy production and tissue repair. The principal intra-cellular target is Cytochrome c Oxidase (CcO), Unit IV of the mitochondrial respiratory chain. In hypoxic or inflamed musculoskeletal tissues, nitric oxide (NO) binds to CcO, suppressing ATP synthesis. LED photon absorption photodissociates NO, restoring oxygen consumption, upregulating ATP production, and initiating microvascular vasodilation and anti-inflammatory signaling.

Primary AcceptorCytochrome c OxidaseMitochondrial Unit IV
Optical Window600 nm to 1000 nmLow Water/Hgb Absorption
Target Tissue Dose2.0 to 10.0 J/cm²Bio-Stimulatory Window
Tissue Loss Rate~50% per 1.0 cmExponential Scattering

Interactive Clinical LED Dosimetry Calculator

Calculate required surface energy density J/cm², exposure duration, and total energy based on target tissue depth and LED equipment parameters.

1. Clinical Treatment Parameters

2.5 cm
Examples: 0.5cm (Wrist/Ankle), 2.5cm (Knee/Cervical), 4.0cm+ (Lumbar/Hip)
5.0 J/cm²
Recommended WALT target dose: 2.0 - 10.0 J/cm² at pathological tissue.

2. LED Emitter Output Parameters

Calculated Clinical Dosimetry Outputs*

Required Surface Energy DensityScales for ~50% attenuation per 1.0cm depth
28.3 J/cm²
Treatment DurationTime required to deliver target dose
7 min 33 sec
Total Optical Energy DeliveredTotal Joules across array area
11313.7 Joules
Status: Optimal bio-stimulatory window. Target fluence is within the recommended therapeutic range of 2.0 to 10.0 J/cm².

Photobiological Kinetics & Tissue Penetration Physics

Visualizing the Arndt-Schulz biphasic dose-response law and Beer-Lambert light attenuation models across tissue depth.

Arndt-Schulz Biphasic Kinetics Curve*

Bio-stimulation versus bio-inhibition zones across delivered photon fluence.

Sub-threshold doses fail to activate Cytochrome c Oxidase. Doses exceeding 10 to 15 J/cm² at target tissue induce excessive ROS, cellular fatigue, and bio-inhibition.

Optical Attenuation Across Tissue Depth*

Exponential loss of light intensity modeled by Beer-Lambert law I(d) = I_0 * e^(-mu_eff*d).

NIR Band II 880-950nm exhibits maximum depth transmission, whereas Visible Red 630-670 nm attenuates rapidly within superficial dermal layers below 1.0 cm.

Wavelength Band Penetration & Chromophore Profile*

Comparative effective penetration depths across clinical optical bands.

Visible Red (630 - 670 nm)Superficial (0.5 - 1.0 cm). Absorbed by melanin and hemoglobin. Ideal for dermatological wounds and superficial tendons.
NIR Band I (780 - 850 nm)Moderate-Deep (2.0 - 3.5 cm). High Cytochrome c Oxidase resonance. Ideal for knee, elbow, and cervical facets.
NIR Band II (880 - 950 nm)Deepest (3.0 - 5.0+ cm). Minimal water absorption peak. Essential for lumbar discs, deep facets, and gluteal fascia.

Anatomical Protocols & WALT Dosage Benchmarks*

Reference parameters for physical therapy and chiropractic interventions across specific anatomical target regions.

Body RegionPathological TargetTarget DepthWavelength SpectrumWALT Dose / PointSurface Energy DensityClinical Frequency
Cervical SpineFacet Joints, Nerve Roots2.0 - 3.5 cm780 - 905 nm4.0 - 16.0 J40 - 80 J/cm²3x/week for 4 weeks (12 sessions)
Lumbar SpineIntervertebral Discs, Facets3.5 - 5.0+ cm808 - 905 nm4.0 - 16.0 J160 - 320 J/cm²3x/week for 4 weeks
Shoulder (Glenohumeral)Supraspinatus, Joint Capsule2.0 - 3.0 cm780 - 904 nm4.0 - 8.0 J40 - 80 J/cm²2 to 3x/week for 3 to 4 weeks
Elbow (Lateral Epicondyle)Common Extensor Tendon0.5 - 1.5 cm660 - 830 nm2.0 - 4.0 J20 - 40 J/cm²2 to 3x/week for 2 to 3 weeks
Wrist / HandCarpal Tunnel, PIP/MCP Joints0.5 - 1.0 cm633 - 830 nm1.0 - 4.0 J10 - 20 J/cm²3x/week for 3 to 4 weeks
Hip JointJoint Capsule, Trochanter3.5 - 5.0+ cm808 - 905 nm4.0 - 12.0 J160 - 320 J/cm²2 to 3x/week for 4 weeks
Knee JointMeniscus, Patellar Tendon1.5 - 2.5 cm780 - 904 nm4.0 - 12.0 J40 - 80 J/cm²3x/week for 4 weeks (12 sessions)
Ankle / FootAchilles Tendon, Plantar Fascia0.5 - 1.5 cm660 - 904 nm2.0 - 8.0 J20 - 40 J/cm²3x/week for 3 weeks (9 sessions)
Acute versus chronic dosing rules: During the acute phase (Days 1 to 5), initiate at the lower dose bound 2.0 - 4.0 J/point to accommodate cellular hyper-reactivity. For sub-acute and chronic remodeling, scale toward 6.0 - 12.0 J/point. Taper energy density down by ~30% when inflammatory markers normalize.

LED Modality Paradigm Comparison

Evaluating operational mechanics, power outputs, and delivery speeds between targeted probes and high-output arrays.

Standard Targeted LED Probes

Stationary Point
  • Power Level: 5W to 20W Wand.
  • Primary Delivery: Firm stationary contact directly over focal point trigger or acupoints.
  • Tissue Compression Effect: Pressing the wand blanches surface capillary hemoglobin and reduces the subcutaneous layer by up to 1.0 cm, increasing photon penetration depth by ~30 to 50%.
  • Time to Deliver 10 J/cm² (to 1 cm depth): ~15 minutes (at 25 mW/cm² surface intensity).
  • Target Area: Focal discrete sites below 100 cm².
Best Application: Trigger point therapy, small joint articulations (carpal/tarsal), localized tendon insertions.

High-Output LED Panels

Broad Regional
  • Power Output: Above 100 W up to 400 W continuous array panels.
  • Primary Delivery: Broad stationary panel positioning.
  • Reciprocity Breakdown Protection: Spreading high total power across large areas 100 - 600 cm² maintains local power density within non-thermal stimulative thresholds.
  • Time to Deliver 10 J/cm² (to 2 cm depth): ~6.7 minutes (at 100 mW/cm² surface intensity).
  • Target Area: Broad anatomical zones 100 - 600 cm².
Best Application: Multi-segmental spine (lumbar/cervical), large muscle groups (quadriceps/hamstrings), high-volume clinic throughput.

Clinical Integration & Rehabilitation Workflow

Optimizing therapy sequence for physical therapy exercise and chiropractic adjustment synergy.

Step 1: Pre-Exercise / Pre-Adjustment

PBMT Administration (5 to 10 min prior)

Apply light therapy 5 to 10 minutes prior to active exercise or joint mobilization. Photons induce photodissociation of nitric oxide, boosting intracellular ATP reserves and enhancing local microvascular perfusion.

Step 2: Ergogenic & Ergonomic Modulation

Performance & Pain Mitigation

Pre-treatment suppresses pre-existing muscular hyperalgesia and buffers against exercise-induced oxidative damage. Studies show 500mW+ applied to major muscle groups delays muscular fatigue and increases total repetitions.

Step 3: Post-Treatment Recovery

Active Rehab & Soft Tissue Repair

Follow light therapy immediately with mechanically loaded movement, joint mobilization, or chiropractic adjustments. Elevated intracellular ATP and reduced cytokine activity accelerate long-term collagen remodeling.

Disclaimer

This dashboard is an educational and informational reference tool for licensed practitioners. The figures, dose ranges, and protocols shown are general references drawn from the broader photobiomodulation literature. They are not medical advice, a prescription, or a guaranteed treatment outcome. Clinicians are responsible for their own clinical judgment, device settings, and patient care decisions. Individual outcomes vary. Final wording is subject to review under TheraLuma's compliance and regulatory process.

TheraLuma Assistant

Hi, I'm the TheraLuma assistant. How can I help you today?